I'm sure I'm showing my ignorance here, but since clinical diagnostics is not limited to patient information and may involve donor information as well, do our efforts need to consider ISBT 128 ?
Ruud
<-----Original Message----->
>From: Solomon, Harry \(GE Healthcare\) [
Harry....@med.ge.com]
>Sent: 2/7/2012 12:36:28 PM
>To:
clinicalfl...@googlegroups.com
>Subject: RE: Clinical Flow Cytometry Standards Next Steps
>
>CAP is already a member of IHE and DICOM (and actually is the
>sponsor/secretariat for IHE AP, IHE Lab, and DICOM WG-26). CLIA just executed a
>“Statement of Understanding” liaison with HL7, and I think there are participant
>in the CLIA standards committee that are also active in IHE Lab.
>
>- Harry Solomon
>Interoperability Architect
>GE Healthcare
>From:
clinicalfl...@googlegroups.com
>[mailto:
clinicalfl...@googlegroups.com] On Behalf Of Ruud Hulspas
>Sent: Tuesday, February 07, 2012 10:08 AM
>To:
clinicalfl...@googlegroups.com
>Subject: Re: Clinical Flow Cytometry Standards Next Steps
>
>I like the summary.
>Should CLIA and CAP specifically be mentioned as participating entities, or are
>they automatically involved through ICCS ?)
>
>Ruud
>
>
>
>
Care2 makes it easy for everyone to live a healthy, green lifestyle
and impact the causes you care about most. Over 12 Million members!
http://www.care2.com
Feed a child by searching the web! Learn how http://www.care2.com/toolbar